《新股表现》常达(01433.HK)暗盘高开2%报0.255元
根据辉立交易平台显示,明天挂牌的常达控股(01433.HK)暗盘高开2%报0.255元,最多升6%高见0.265元乏力,掉头低见0.181元,现造0.185元,较上市价0.25元,低开26%,成交1,740万股。
常达是服装标签及装饰产品生产商,公司生产设施位於中国、孟加拉及越南,并於美国设有支援生产线。是次上市共发售5亿股,其中10%公开发售获近74倍超购,已启动回拨机制占比增至40%,认购一手中签率70%;股份以招股范围(0.25-0.29元)下限定价,料集资净额约7,490万元,主要用作建设新孟加拉厂房与购买机器,以及用作中国厂房购买机器等。上市独家保荐人千里硕。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.